NMR Reaction-Monitoring as a Process Analytical Technique - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

NMR Reaction-Monitoring as a Process Analytical Technique
The authors describe the benefits of nuclear magnetic resonance (NMR) compared with traditional monitoring techniques. They also discuss how NMR reaction monitoring provides a new process analytical technology tool for industry.


Pharmaceutical Technology
pp. s19-s21

NMR reaction-monitoring systems


Figure 1: Basic NMR reaction monitoring setup.
The use of NMR as a reaction-monitoring tool has increased in recent years (3, 4). The basic process involves removing a flowing stream of the reaction mixture from the reactor vessel, which is then pumped to the magnet using tubing. There, it enters a flow cell in the rf coil region of the probe before being returned to the reaction vessel (see Figure 1). The volume removed from the reactor at any one time is typically less than 5 mL; h flow rates depend on the experimental setup, but should be slow enough to give sufficient residence time in the high magnetic field region to assure adequate polarization and minimize the T1 bias to peak areas (5).

Many of the reports on NMR reaction monitoring have employed the use of flow cells that are fixed inside the probe, but modified NMR tubes have been used as a low cost alternative (6, 7). The replacement of these flow tubes is considered easier than replacing flow cell probes, which have to be returned to the vendor for repairs and can result in instrument downtime if additional flow probes are not available. Flow tubes offer the added advantage that any spectrometer with a conventional probe may be readily converted to be used for NMR reaction monitoring, thereby allowing for the analysis of a wide range of NMR active nuclei and temperatures.

Flow NMR can be used to investigate batch reactions. The technique also lends itself to monitoring flow and continuous reactions. The output from a packed bed or thermal tube reactor can be simply diverted to the flow NMR for in-line analysis of the product stream.

Data processing


Figure 2: Data processing of multiple NMR spectra, showing the hydrolysis of acetic anhydride as a simple model reaction.
Advances in instrumentation facilitate the generation of large amounts of data and the potential to uncover vast amounts of information. Processing of multiple individual spectra (typically > 100) proved time-consuming and labor-intensive; therefore an efficient method of processing and mining the data was needed if this method of reaction monitoring was to be viable. The development of automated processing software has expedited this procedure, allowing hundreds of 1-D NMR spectra to be processed and useful information extracted in a matter of minutes (8). Peak and spectral alignment algorithms provide the ability to accurately integrate a particular resonance of interest whose chemical shift may migrate across the spectrum during the course of a reaction. Exploiting the fact that under the correct experimental conditions the integral for a particular signal can be directly correlated to the concentration of that species, a graphical representation of concentration versus time is generated, thereby providing an accurate picture of the reaction's progress (see Figure 2). The data generated may then be transferred to various kinetic and modeling software packages to produce kinetic results for chemists and engineers. Offline, stopped flow, or on-flow 2-D NMR experiments can be conducted to determine the nature of reactive intermediates formed during the course of the reaction.

Application to the pharmaceutical industry

The value of NMR reaction monitoring has been increasingly documented in the literature and is being implemented in the development of multiple synthetic steps by groups at Pfizer, Lilly, Roche, and AstraZeneca, to name but a few (4, 9–11). A recent report on the optimization of the synthesis of an imidazole derivative demonstrated the value of flow NMR reaction monitoring for understanding the formation of an undesired byproduct (11). The process proceeded through an intermediate that could not be detected by other analytical techniques because of the instability of the intermediate. However, examination of the process by flow NMR allowed the detection and characterization of this intermediate as well as elucidation of the mechanism of the reaction. As a result, a method of producing the required imidazole as the sole product was found.

Conclusion

In summary, NMR technology is a valuable addition to the arsenal of PAT tools currently available in the pharmaceutical industry. The detailed picture of a process that is gained from a single experiment provides valuable information and a deeper understanding for scientists across a broad range of disciplines. This knowledge enables a robust process to emerge from the process research and development stage of drug development.

David A. Foley is a postdoctoral fellow, Mark T. Zell is a senior principal scientist, and Brian L. Marquez* is an associate research fellow, all at Pfizer Global Research and Development, Groton/New London Laboratories,
. Andreas Kaerner is a research advisor in analytical sciences R&D at Eli Lilly and Company.

*To whom all correspondence should be addressed.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here